Compounds > isotretinoin

isotretinoin and Hepatolenticular-Degeneration

isotretinoin has been researched along with Hepatolenticular-Degeneration* in 2 studies

Other Studies

2 other study(ies) available for isotretinoin and Hepatolenticular-Degeneration

ArticleYear
Erythematous plaques on the flexural surfaces.
    Archives of dermatology, 2005, Volume: 141, Issue:11

    Topics: Adult; Antirheumatic Agents; Axilla; Diagnosis, Differential; Drug Eruptions; Female; Hepatolenticular Degeneration; Humans; Isotretinoin; Keratolytic Agents; Neck; Penicillamine

2005
Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin.
    Dermatology (Basel, Switzerland), 1994, Volume: 189, Issue:1

    Elastosis perforans serpiginosa (EPS) and the elastotic changes of pseudoxanthoma elasticum (PXE) are rare but well-recognized side-effects of long-term penicillamine therapy. A 42-year old female patient who developed both of these cutaneous side-effects following treatment with high-dose penicillamine for Wilson's disease is described; near-complete resolution of the EPS, but not the PXE was achieved by treatment with isotretinoin (0.5 mg/kg/day) for 6 weeks, despite continuation of the penicillamine.

    Topics: Adult; Elastic Tissue; Female; Hepatolenticular Degeneration; Humans; Isotretinoin; Penicillamine; Pseudoxanthoma Elasticum; Skin Diseases

1994